We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Pharmacovigilance – Products

A female scientist holding a vial.
Product News

Sapient’s High Complexity CLIA Laboratory Receives Accreditation From the College of American Pathologists

Sapient has been awarded accreditation from the College of American Pathologists (CAP).
Cell culture in a 12-well plate.
Product News

InSphero AG and Cosmo Bio Co., Ltd Enter Into Strategic Partnership

InSphero AG and Cosmo Bio Co., Ltd. are announcing a strategic partnership to distribute InSphero’s innovative product portfolio in Japan.
Artistic illustration of antibodies.
Product News

Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis

TVM Capital Life Science, together with specialty pharma company, Tillotts Pharma has announced that the companies will jointly invest up to USD 28 million in the newly formed U.S.-based biotechnology company, Mage Biologics Inc.
Various types of oral medication on a yellow background.
Product News

Landmark Study Demonstrates Economic Edge of Precision Medicine

A landmark study demonstrates that precision oncology medicines could deliver a superior return on Investment for Pharma R&D vs their one size fits all counterparts.
OncoPro Tumoroid Culture Medium Kit
Product News

Thermo Fisher Scientific Introduces Tumoroid Culture Medium

Thermo Fisher Scientific has announced the launch of the first commercially available culture medium specifically developed for the expansion of patient-derived cancer organoids, from multiple cancer indications.
Sygnature Discovery logo.
Product News

Sygnature Discovery Launches Its LPS In Vivo Model To Profile Early-Stage Anti-Inflammatory Drugs

Sygnature Discovery has established an in vivo LPS model of inflammation which can help understand life-limiting neuroinflammatory conditions like Parkinson’s disease, multiple sclerosis, Alzheimer’s disease, and traumatic brain injuries and identify new drug targets.
The Avacta logo
Product News

Avacta Announces Successful Completion of Fifth Dose Escalation in AVA6000 Phase I Clinical Study

Avacta Group plc has announced that the fifth dose escalation cohort in the ALS-6000-101 dose escalation Phase 1 clinical trial to evaluate the safety and tolerability of AVA6000 has been completed successfully.
App Note / Case Study

Optimizing Organoid Culture Conditions

This application note outlines the importance of reagent consistency in organoid tissue culture.
The Signals Research Suite software.
Product News

Revvity Launches First Scientific SaaS Platform to Accelerate Drug and Materials Development

Revvity, Inc announced the launch of its Signals Research Suite, a unified, cloud-native SaaS platform that drives scientific collaboration across R&D disciplines from drug discovery to specialty chemicals material development.
Remegen logo.
Product News

ASCO 2023: RemeGen Exhibits Promising Results of Disitamab Vedotin in Bladder Cancer

RemeGen Co., Ltd announced the latest clinical research results on disitamab vedotin at this year's American Society of Clinical Oncology Annual Meeting.